Calypte!!! Was seht ihr als realistisches Kursziel

fröhliches gruseln, zittern und bangen mit CYPT (Ihr wollt's ja nicht anders ;-))), vor allem aber 'n schönes langes WE
Bis dann, ZN  

wer nich zu sich ehrlich sein kann,belügt auch den rest der welt:)
kram  

 

 

 

 

      Marr Technologies Increases Investment in Calypte Biomedical Corporation  
       THURSDAY, OCTOBER 02, 2003 12:55 PM
- PR Newswire

ALAMEDA, Calif., Oct 2, 2003 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (CYPT) , the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, announced today that Marr Technologies Limited had increased its ownership in Calypte Biomedical through the open-market purchase of approximately 5.2 million shares of the company's common stock. Marr had previously invested $12.5 million in the company's stock through a private placement of securities.

"We are confident in Calypte's HIV screening technology," said Marat Safin, President of Marr Technologies Limited. "We believe it will penetrate the global markets. Since the company is already well financed, we have acquired an additional 5.2 million shares in the company in the open market."

The recent purchases increase Marr's ownership position to approximately 38 million shares.

About Marr Technologies Limited

Marr Technologies Limited is a member of the Marr Group of companies (the "Group"). The Group is a private group controlled by the Safin family and administered from London. Marat Safin, a London School of Economics graduate, is the President of the Group. The Group has a large and diverse number of investments and projects globally, principally in Europe, the Far East, the Middle East and the CIS, with substantial investments in telecoms and technology projects. The Group has made significant progress in placing products and services of its group companies in the Chinese market and believes that its experience in China will greatly benefit the joint venture with Calypte.


 

 

sehen: 1.125 marke wird nachhaltig genommen und gen norden gehts weiter..  

 

 

jetzt noch ne Flasche Wein!! Alles wird wieder gut!! Auf in ein schönes Wochenende!! Glückwunsch an die, die noch nachgelegt haben. Wenn da mal kein insider den Kurs in USA gedrückt hat um nochmal kräftig einzusammeln dann weiss ich nicht!! aufjedenfall glückwunsch an alle die dabei geblieben sind!!
Gruss Sam  

man könnte dir eigentlich auch ein hellseher-laden aufmachen. der verdienst soll nicht so schlecht sein..  

Marr Technologies Increases Investment in Calypte BiomedicalCorporation  
 
ALAMEDA, Calif., Oct 2, 2003 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, announced today that Marr Technologies Limited had increased its ownership in Calypte Biomedical through the open-market purchase of approximately 5.2 million shares of the company's common stock. Marr had previously invested $12.5 million in the company's stock through a private placement of securities.

"We are confident in Calypte's HIV screening technology," said Marat Safin, President of Marr Technologies Limited. "We believe it will penetrate the global markets. Since the company is already well financed, we have acquired an additional 5.2 million shares in the company in the open market."

The recent purchases increase Marr's ownership position to approximately 38 million shares.

 

Hey, ich glaube einfach an den Laden..und folgender Satz aus der PR lässt einen doch die ände reiben:
"We believe it will penetrate the global markets."  

 

Marr Technologies Increases Investment in Calypte BiomedicalCorporation  

 

 

 

 

 

nehme alles zurück, leider doch keine news, zumindest für den nicht, der das gestrige filing bereits gelesen hat.

Gruß, sireuitz  

Inzwischen haben wir sogar zwei Meldungen per Week! Es kommt Bewegung in den Laden!
Hinzu kommen noch die SEC Fillings, die den Titel ins Gespräch bringen! Jetzt haben wir doch, was wir wollten. Die $1-Marke wurde getestet und es ist klar, dass der urs nicht darunter fallen soll/wird!!!


2-Oct-2003  Marr Technologies Increases Investment in Calypte Biomedical Corporation  
1-Oct-2003  Calypte Biomedical Corporation Plans New Initiative With The AIDS Action Council In Africa  
24-Sep-2003  Calypte Biomedical to Test its Urine Based HIV-1 Test in Tanzania, Rwanda, Burundi and Botswana  
9-Sep-2003  Calypte's HIV-1 Antibody Tests Approved For Distribution in the Republic of Uganda  
2-Sep-2003  Calypte Receives $10 Million Investment  
26-Aug-2003  Calypte and World Health Organization Reach Agreement to Accelerate Review Of HIV EIA and Western Blot Evaluations Phase 2 No Longer Required  
12-Aug-2003  Calypte Biomedical Announces Resumption of Product Distribution in China  
 

*g*